koo,  .16 usd is not the true EV of Zenith, i would say based on the past Zenith pp at $1.00 to  $1.50 per share has Zenith at $225 Mil usd EV  . Lets say we use a 7 to 1 multiple puts a buyout price at $1.6 Billion usd or $10 per share and thats at an early part of development before any FDA approval of any of the indications. Price for a buyout  of Zenith will go up expodentially if there is just one FDA approval.  So for a BP if there are a strong believer in the science which many seem to be then either pay the $1.6 billion now or wait for an approval and pay 5  to 10 times more....